- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical considerations for the design of PROTACs in cancer
Authors
Keywords
-
Journal
Molecular Cancer
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-03-07
DOI
10.1186/s12943-022-01535-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficient targeted oncogenic KRASG12C degradation via first reversible-covalent PROTAC
- (2022) Fang Yang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Targeting pan-essential genes in cancer: challenges and opportunities
- (2021) Liang Chang et al. CANCER CELL
- Effective degradation of EGFRL858R+T790M mutant proteins by CRBN-based PROTACs through both proteosome and autophagy/lysosome degradation systems
- (2021) Xiaojuan Qu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Emerging Trends in Cancer Drug Discovery—From Drugging the “Undruggable” to Overcoming Resistance
- (2021) Joachim Rudolph et al. Cancer Discovery
- The rise of covalent proteolysis targeting chimeras
- (2021) Ronen Gabizon et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- The PROTACtable genome
- (2021) Melanie Schneider et al. NATURE REVIEWS DRUG DISCOVERY
- Receptor tyrosine kinases and cancer: oncogenic mechanisms and therapeutic approaches
- (2021) Punit Saraon et al. ONCOGENE
- Proteolysis targeting chimeras (PROTACs) in cancer therapy
- (2020) Alberto Ocaña et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Modelling dose and schedule effects of AZD2811 nanoparticles targeting aurora kinase B for treatment of diffuse large B-cell lymphoma
- (2019) Nicolas Floc'h et al. MOLECULAR CANCER THERAPEUTICS
- Systematic identification and validation of the reference genes from 60 RNA-Seq libraries in the scallop Mizuhopecten yessoensis
- (2019) Yajuan Li et al. BMC GENOMICS
- Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma
- (2019) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity
- (2019) Sajid Khan et al. NATURE MEDICINE
- Refining Early Antitumoral Drug Development
- (2018) Alberto Ocaña et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- UbiHub: a data hub for the explorers of ubiquitination pathways
- (2018) Lihua Liu et al. BIOINFORMATICS
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
- (2017) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- BET inhibitors as novel therapeutic agents in breast cancer
- (2017) Alberto Ocaña et al. Oncotarget
- Oncogene addiction: pathways of therapeutic response, resistance, and road maps toward a cure
- (2015) R. Pagliarini et al. EMBO REPORTS
- Identification and characterization of essential genes in the human genome
- (2015) T. Wang et al. SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now